Biostatsisticians are critical for translating new cancer discoveries into clinical tests and assays that can benefit patients.  Dr. Dobbin’s focus is the are of treatment selection biomarkers, which are biological measurements used to make clinical decisions about which treatment a patient should receive.  His research also spans into multiplex and high dimensional assays, and related issues of reproducibility and computational methods.

CV

Bibliography